Maravai (MRVI) Advances in RNA Research With New Collaboration
Maravai LifeSciences’ MRVI business, TriLink BioTechnologies, recently partnered with Johns Hopkins University to significantly enhance research in RNA therapeutics.
Investors Interested In Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Revenues
When you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3.4x, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) lo
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Maravai LifeSciences | 10-Q: Quarterly report
Express News | Maravai LifeSciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed FY24 Revenue Guidance. Also, Baird Maintained an Outperform Rating on the Stock and Raised Its Price Target...
Express News | Maravai LifeSciences Holdings Inc : UBS Raises Target Price to $8.5 From $6.5
Maravai Lifesciences: A Strong Buy on Strategic Positioning and Operational Leverage
Maravai LifeSciences Is Maintained at Outperform by Baird
Maravai LifeSciences Is Maintained at Outperform by Baird
Express News | Baird Maintains Outperform on Maravai LifeSciences, Raises Price Target to $10
Maravai LifeSciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 14.94% Baird $8 → $10 Maintains Outperform 04/10/2024 72.41% Craig-Hallum → $15 Initiates Cover
Earnings Call Summary | Maravai LifeSciences(MRVI.US) Q1 2024 Earnings Conference
The following is a summary of the Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript:Financial Performance:Maravai LifeSciences reported Q1 2024 revenue of $64 million, surpas
Analysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Arcus Biosciences (RCUS) and Maravai Lifesciences Holdings (MRVI)
Express News | Maravai LifeSciences Reaffirms 2024 Revenue Guidance; Sees Revenue $265M-$285M
Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, Vs. Street Est of $60.5M
04:44 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (MRVI) MARAVAI LIFESCIENCES HOLDINGS LLC Reports Q1 Revenue $64.2M, vs. Street Est of $60.5M
Express News | Maravai LifeSciences Holdings Inc - Revenue Expectations for 2024 Remain in Range of $265.0 Mln to $285.0 Mln
Maravai LifeSciences Q1 2024 Adj EPS $(0.02) Beats $(0.03) Estimate, Sales $64.179M Beat $60.548M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 166.67 percent decrease over earnings
Express News | Maravai LifeSciences Q1 Revenue USD 64.179 Million Vs. Ibes Estimate USD 60.5 Million
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Reaffirmed financial guidance for the full year 2024 including a revenue range of $265.0 million to $285.0 million..
Press Release: Maravai LifeSciences Reports First Quarter 2024 Financial Results
Maravai LifeSciences Reports First Quarter 2024 Financial Results Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE)
Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)